Skip to main content

Hagan Joseph P

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Hagan Joseph P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

RGLS Regulus Therapeutics Inc.

Chief Executive Officer4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2025 (view filing)Jan 301 dayHagan Joseph PChief Executive OfficerPPurchase+50.0K$1.09+$54.5K+23.7%260.8K after
Jan 15, 2025 (view filing)Jan 13-142 daysHagan Joseph PChief Executive OfficerSSale−127.1K$1.26−$160.1K−37.6%210.8K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 18Same dayHagan Joseph PChief Executive OfficerSSale−14.6K$1.19−$17.4K−20.3%57.1K after
Jan 26, 2022 (view filing)4:13 PM ETJan 26Same dayHagan Joseph PPresident and CEOPPurchase+100.0K$0.2152+$21.5K+31.5%417.0K after

AUPH Aurinia Pharmaceuticals Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 23, 2023 (view filing)May 194 daysHagan Joseph PDirectorSSale−272$10.58−$2.88K−2.2%12.0K after
Jan 4, 2022 (view filing)Jan 31 dayHagan Joseph PDirectorSSale−40.0K$22.59−$903.7K−92.0%3.50K after2 lots